Clinical Trial

Electronic Real-Time Heart Team Decision-making vs. Usual Care in Patients With Triple-Vessel Coronary Artery Disease and Diabetes Mellitus

Study acronym: EHEART-3VD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a multi-center randomized controlled trial involving patients with 3-vessel coronary artery disease and diabetes mellitus. Enrolled patients will be dividing into real-time heart team decision-making group (intervention group) and usual care group (control group). The intervention group will conduct a real-time online multidisciplinary heart team discussion and decision-making during coronary angiography. The control group will conduct an usual care decision-making.
Trial Details
NCT Number NCT07326514
Lead Sponsor China National Center for Cardiovascular Diseases
Collaborators: Chinese Academy of Medical Sciences, Fuwai Hospital, The First Affiliated Hospital of Dalian Medical University, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Fuwai Yunnan Cardiovascular Hospital, The First Affiliated Hospital with Nanjing Medical University, Central China Fuwai Hospital of Zhengzhou University, Ruijin Hospital, Nanjing First Hospital, Nanjing Medical University, Shenzhen Sun Yat-sen Cardiovascular Hospital
Conditions Diabetes, Coronary Artery Disease
Enrollment 1,350 participants
Start Date 2026-01-01
Primary Completion 2028-06-01 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-08